CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Moderna received three significant FDA approvals this year, including the next-generation COVID-19 vaccine mNEXSPIKE, mRESVIA ...

Moderna is backing the American Lung Association’s (ALA’s) call for people with lung diseases to get vaccinated for the ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...

Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...

Moderna is asking U.S. regulators to allow for use of its COVID-19 vaccine on the nation's youngest children. Moderna submitted data to the Food and Drug Administration Thursday for emergency use ...

Anxiety is high among parents as more kids head back to school without the protection of a COVID-19 vaccine for at least a few more months. Parents have a reason to be concerned. After months of ...

A key question for investors going forward will be whether Moderna's other latent virus vaccines for Epstein-Barr and ...

While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...